Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$73.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 8 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 247 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 21 most recent Form 4 transactions.
| Jun 11 | PLSE | Pulse Biosciences, INC. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | SMMT | Summit Therapeutics Inc. | PBUY | 100,000 | $14.60 | $1.5M | +0.4% | Open the original filing on SEC.gov |
| May 11 | PLSE | Pulse Biosciences, INC. | PBUY↺ | 660,233 | $19.69 | $13M | +1.4% | Open the original filing on SEC.gov |
| Jan 2 | SMMT | Summit Therapeutics Inc. | AGRANT◆ | 11,232 | $8.76 | $98.4K | — | Open the original filing on SEC.gov |
| Oct 21, 2025 | SMMT | Summit Therapeutics Inc. | PBUY | 26,680 | $18.74 | $500K | +53.4% | Open the original filing on SEC.gov |
| Oct 21, 2025 | SMMT | Summit Therapeutics Inc. | AGRANT | 266,808 | $18.74 | $5M | +1.1% | Open the original filing on SEC.gov |
| Oct 21, 2025 | SMMT | Summit Therapeutics Inc. | AGRANT | 14M | $18.74 | $262M | +2.5% | Open the original filing on SEC.gov |
| Sep 11, 2025 | SMMT | Summit Therapeutics Inc. | PBUY | 5,000 | $18.07 | $90.4K | 0.0% | Open the original filing on SEC.gov |
| Sep 10, 2025 | SMMT | Summit Therapeutics Inc. | PBUY | 333,394 | $17.68 | $5.9M | +<0.1% | Open the original filing on SEC.gov |
| Sep 10, 2025 | PLSE | Pulse Biosciences, INC. | PBUY | 34,659 | $14.66 | $508.1K | +<0.1% | Open the original filing on SEC.gov |
| Aug 15, 2025 | PLSE | Pulse Biosciences, INC. | AGRANT◆ | 20,792 | — | — | — | Open the original filing on SEC.gov |
| Aug 15, 2025 | PLSE | Pulse Biosciences, INC. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| May 30, 2025 | SMMT | Summit Therapeutics Inc. | MEXER◆ | 74,545 | — | — | — | Open the original filing on SEC.gov |
| May 30, 2025 | SMMT | Summit Therapeutics Inc. | MEXER | 74,545 | $2.64 | $196.8K | +<0.1% | Open the original filing on SEC.gov |
| Apr 29, 2025 | SMMT | Summit Therapeutics Inc. | AGRANT◆ | 9.6M | — | — | — | Open the original filing on SEC.gov |
| Apr 29, 2025 | SMMT | Summit Therapeutics Inc. | AGRANT◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 29, 2025 | SMMT | Summit Therapeutics Inc. | AGRANT◆ | 1M | — | — | — | Open the original filing on SEC.gov |
| Sep 12, 2024 | PLSE | Pulse Biosciences, INC. | PBUY | 145,140 | $14.41 | $2.1M | +0.3% | Open the original filing on SEC.gov |
| Sep 11, 2024 | PLSE | Pulse Biosciences, INC. | PBUY | 12,800 | $14.77 | $189.1K | +<0.1% | Open the original filing on SEC.gov |